Absci (ABSI) Other Non-Current Liabilities (2020 - 2026)

Absci's (ABSI) quarterly Other Non-Current Liabilities came in at $806000.0 in Q1 2026, down 52.17% year-on-year from $1.7 million in Q1 2025, and down 21.21% quarter-over-quarter from $1.0 million in Q4 2025.

Absci (ABSI) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Absci has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $806000.0 for Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $806000.0, down 52.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $806000.0 (down 52.17% YoY), and the FY2025 annual result was $1.0 million, up 669.17% from the prior year.
  • Other Non-Current Liabilities came in at $806000.0 for Q1 2026 at Absci, down from $1.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.8 million in Q3 2025 to a low of $15000.0 in Q2 2024.
  • The 5-year median for Other Non-Current Liabilities is $224500.0 (2022), against an average of $560785.7.
  • Across the five-year window, Other Non-Current Liabilities tumbled 99.73% in 2022 and jumped 9780.0% in 2025, its largest moves.
  • Absci's Other Non-Current Liabilities stood at $35000.0 in 2022, then jumped by 742.86% to $295000.0 in 2023, then slumped by 54.92% to $133000.0 in 2024, then soared by 669.17% to $1.0 million in 2025, then retreated by 21.21% to $806000.0 in 2026.
  • The last three Other Non-Current Liabilities figures came in at $806000.0 (Q1 2026), $1.0 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Absci 1.13 Bn 1.01 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 806,000.00
Dec 31, 2025 1.02 Mn
Sep 30, 2025 1.79 Mn
Jun 30, 2025 1.48 Mn
Mar 31, 2025 1.69 Mn
Dec 31, 2024 133,000.00
Sep 30, 2024 31,000.00
Jun 30, 2024 15,000.00
Mar 31, 2024 78,000.00
Dec 31, 2023 295,000.00
Dec 31, 2022 35,000.00
Sep 30, 2022 33,000.00
Jun 30, 2022 227,000.00
Mar 31, 2022 222,000.00
Dec 31, 2021 12.16 Mn
Sep 30, 2021 12.13 Mn
Jun 30, 2021 15.00 Mn
Dec 31, 2020 749,000.00